| TOPIC | MAIN THEME |
|---|---|
| Mechanism-targeted Therapeutics |
Mechanism-targeted Therapeutics Decoding Parkinsonism: Molecular Pathways, Biomarkers, and Translational Future Directions |
| Biomarkers and Systemic Mechanisms in Parkinson's Disease: Neuroinflammation, Metabolism, and Early Detection | |
| Genetics and Translational Pathways in Ataxia and Hyperkinetic Movement Disorders | |
| Innovations in Parkinson's Disease Treatment and Neuroprotection | |
| Therapeutics | Advances in the Evidence-based Treatment in Parkinson’s Disease |
| Innovation of Movement Disorder Clinics | |
| Managing Parkinsonism: Current Challenges, Advances, and the Transformation of Patient Care | |
| Frontier in Restorative Medicine: Advanced and Future Therapeutic Strategies for Parkinson's Disease | |
| Frontier in Patient Care: Future Direction of Advanced Therapies for Movement Disorders | |
| Innovations in Atypical Parkinsonism Research and Management | |
| Advancing Treatments for Ataxia and Hyperkinetic Movement Disorders | |
| Diagnosis and Management of Special Movement Disorders | |
| Neurophysiology | Neurophysiological Assessment in Movement Disorders |
| Neural Mechanisms of Movement Control | |
| Neuroimage | Integrating Clinical, Molecular Biomarkers, and Neuroimaging Perspectives |
| Neuromodulationy | Deep Brain Stimulation in Movement Disorders: Case Studies and Troubleshooting |
| Neuromodulation for Movement Disorders: Stimulation and Ultrasound | |
| Deep Brain Stimulation and Neurophysiological Strategies for Movement Disorder Treatment | |
| Hyperkinetic | Genetics and Translational Pathways in Ataxia and Hyperkinetic Movement Disorders |
| Advancing Treatments for Ataxia and Hyperkinetic Movement Disorders |
